OBJECTIVE: Interleukin-33 (IL-33) is the newest member of the IL-1 cytokine family, a group of key regulators of inflammation. The purpose of this study was to determine whether IL-33 is expressed in the human placenta and to investigate its expression in the context of acute and chronic chorioamnionitis. METHODS: Placental tissues were obtained from five groups of patients: 1) normal pregnancy at term without labor (n = 10); 2) normal pregnancy at term in labor (n = 10); 3) preterm labor without inflammation (n = 10); 4) preterm labor with acute chorioamnionitis and funisitis (n = 10); and 5) preterm labor with chronic chorioamnionitis (n = 10). Immunostaining was performed to determine IL-33 protein expression patterns in the placental disk, chorioamniotic membranes, and umbilical cord. mRNA expression of IL-33 and its receptor IL1RL1 (ST2) was measured in primary amnion epithelial and mesenchymal cells (AECs and AMCs, n = 4) and human umbilical vein endothelial cells (HUVECs, n = 4) treated with IL-1β (1 and 10 ng/ml) and CXCL10 (0.5 and 1 or 5 ng/ml). RESULTS: 1) Nuclear IL-33 expression was found in endothelial and smooth muscle cells in the placenta, chorioamniotic membranes, and umbilical cord; 2) IL-33 was detected in the nucleus of CD14+ macrophages in the chorioamniotic membranes, chorionic plate, and umbilical cord, and in the cytoplasm of myofibroblasts in the Wharton's jelly; 3) acute (but not chronic) chorioamnionitis was associated with the presence of IL-33+ macrophages in the chorioamniotic membranes and umbilical cord; 4) expression of IL-33 or IL1RL1 (ST2) mRNA in AECs was undetectable; 5) IL-33 mRNA expression increased in AMCs and HUVECs after IL-1β treatment but did not change with CXCL10 treatment; and 6) IL1RL1 (ST2) expression decreased in AMCs and increased in HUVECs after IL-1β but not CXCL10 treatment. CONCLUSIONS: IL-33 is expressed in the nucleus of placental endothelial cells, CD14+ macrophages, and myofibroblasts in the Wharton's jelly. IL-1β can induce the expression of IL-33 and its receptor. Protein expression of IL-33 is detectable in macrophages of the chorioamniotic membranes in acute (but not chronic) chorioamnionitis.
OBJECTIVE:Interleukin-33 (IL-33) is the newest member of the IL-1 cytokine family, a group of key regulators of inflammation. The purpose of this study was to determine whether IL-33 is expressed in the human placenta and to investigate its expression in the context of acute and chronic chorioamnionitis. METHODS: Placental tissues were obtained from five groups of patients: 1) normal pregnancy at term without labor (n = 10); 2) normal pregnancy at term in labor (n = 10); 3) preterm labor without inflammation (n = 10); 4) preterm labor with acute chorioamnionitis and funisitis (n = 10); and 5) preterm labor with chronic chorioamnionitis (n = 10). Immunostaining was performed to determine IL-33 protein expression patterns in the placental disk, chorioamniotic membranes, and umbilical cord. mRNA expression of IL-33 and its receptor IL1RL1 (ST2) was measured in primary amnion epithelial and mesenchymal cells (AECs and AMCs, n = 4) and human umbilical vein endothelial cells (HUVECs, n = 4) treated with IL-1β (1 and 10 ng/ml) and CXCL10 (0.5 and 1 or 5 ng/ml). RESULTS: 1) Nuclear IL-33 expression was found in endothelial and smooth muscle cells in the placenta, chorioamniotic membranes, and umbilical cord; 2) IL-33 was detected in the nucleus of CD14+ macrophages in the chorioamniotic membranes, chorionic plate, and umbilical cord, and in the cytoplasm of myofibroblasts in the Wharton's jelly; 3) acute (but not chronic) chorioamnionitis was associated with the presence of IL-33+ macrophages in the chorioamniotic membranes and umbilical cord; 4) expression of IL-33 or IL1RL1 (ST2) mRNA in AECs was undetectable; 5) IL-33 mRNA expression increased in AMCs and HUVECs after IL-1β treatment but did not change with CXCL10 treatment; and 6) IL1RL1 (ST2) expression decreased in AMCs and increased in HUVECs after IL-1β but not CXCL10 treatment. CONCLUSIONS:IL-33 is expressed in the nucleus of placental endothelial cells, CD14+ macrophages, and myofibroblasts in the Wharton's jelly. IL-1β can induce the expression of IL-33 and its receptor. Protein expression of IL-33 is detectable in macrophages of the chorioamniotic membranes in acute (but not chronic) chorioamnionitis.
Authors: Axel M Küchler; Jürgen Pollheimer; Johanna Balogh; Jon Sponheim; Linda Manley; Dag R Sorensen; Paula M De Angelis; Helge Scott; Guttorm Haraldsen Journal: Am J Pathol Date: 2008-09-11 Impact factor: 4.307
Authors: Yu Mi Han; Roberto Romero; Jung-Sun Kim; Adi L Tarca; Sun Kwon Kim; Sorin Draghici; Juan Pedro Kusanovic; Francesca Gotsch; Pooja Mittal; Sonia S Hassan; Chong Jai Kim Journal: Biol Reprod Date: 2008-08-06 Impact factor: 4.285
Authors: P L Fidel; R Romero; M Ramirez; J Cutright; S S Edwin; S LaMarche; D B Cotton; M D Mitchell Journal: Am J Reprod Immunol Date: 1994-08 Impact factor: 3.886
Authors: M Sakashita; T Yoshimoto; T Hirota; M Harada; K Okubo; Y Osawa; S Fujieda; Y Nakamura; K Yasuda; K Nakanishi; M Tamari Journal: Clin Exp Allergy Date: 2008-12 Impact factor: 5.018
Authors: Daniel B DiGiulio; Roberto Romero; Harold P Amogan; Juan Pedro Kusanovic; Elisabeth M Bik; Francesca Gotsch; Chong Jai Kim; Offer Erez; Sam Edwin; David A Relman Journal: PLoS One Date: 2008-08-26 Impact factor: 3.240
Authors: Nuriban Valero-Pacheco; Eric K Tang; Noura Massri; Rachel Loia; Anat Chemerinski; Tracy Wu; Salma Begum; Darine W El-Naccache; William C Gause; Ripla Arora; Nataki C Douglas; Aimee M Beaulieu Journal: Proc Natl Acad Sci U S A Date: 2022-08-22 Impact factor: 12.779
Authors: Jennifer H Southcombe; Nathalie Lédée; Sophie Perrier d'Hauterive; Karen Turner; Tim Child; James V Snider; Christopher W G Redman; Ian L Sargent; Ingrid Granne Journal: PLoS One Date: 2013-09-10 Impact factor: 3.240